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Abstract: The Lippia alba species consists of an aromatic plant used in Brazilian traditional medical practice and in the medical practice of 
several countries as well. Presenting a wide variability in its essential oil chemical composition, the Lippia alba is classified in chemotypes, 
or chemical races, according to the major constituents contained in its essential oil. Considering the quali and quantitative distribution of the 
components in the essential oil affect directly its pharmacological properties, which are presented in the medicinal species, this paper 
proposes a scientific literature review to correlate both biological and pharmacological properties presented by L. alba according to its 
chemical constitution. 
  









Resumen: Lippia alba es una planta aromática utilizada en la medicina tradicional de Brasil y de varios países. Con una gran variabilidad en 
la composición química de su aceite esencial, se clasifica en quimiotipos, o razas químicas, de acuerdo con los constituyentes mayoritarios 
presentes en el aceite esencial. Dado que la distribución cualitativa y cuantitativa de los componentes del aceite esencial afecta directamente 
a las propiedades farmacológicas presentadas por la especie medicinal, este trabajo propone realizar una revisión en la literatura científica 
para correlacionar las propiedades biológicas y farmacológicas de los quimiotipos presentes en el aceite essencial de la L. alba. 
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In Brazil, there are several species of plants validated 
as medicinal, among them, the “erva-cidreira” or 
“falsa-melissa”, also known as Lippia alba (mill.) 
N.E. Brown, appears in all regions throughout the 
country. The Lippia genus consists of 200 species 
widely distributed throughout South America, 
Central America and across Africa (Zoghbi et al., 
1998). 
The L. alba is an aromatic plant known for its 
wide variability in its essential oil chemical 
composition (Tavares et al., 2005). In general, the 
chemical composition of essential oils changes – both 
qualitatively and quantitatively – due soil conditions, 
rainfall, geographic region, variety, plant age and 
extraction method (Jerkovic et al., 2001; Bagamboula 
et al., 2004). However, some authors suggest that the 
chemotype, or the chemical race, determines the 
chemical composition of essential oils (Castro et al., 
2002; Simões et al., 2003; Tavares et al., 2005; 
Manica-Cattani et al., 2009). The classification of 
aromatic plants in chemotypes is very important, 
since it affects directly the active components, and 
thus, the pharmacological properties presented in 
their derivatives, either extracts or essential oil. 
Several studies were conducted with L. alba 
from different regions demonstrated a wide 
variability in morphology and its chemical 
constitution, and these variations could not be 
explained by soil and climate conditions. According 
to Simões (2003), different plants grown in identical 
soil had different products, whereas similar plants 
grown in completely different soil displayed similar 
constituents. Some studies highlight that the L. alba 
genetic variation is not related to its geographical 
area, but to its chemotype (Manica-Cattani et al., 
2009). 
L. alba morphological and chemical 
variations allow distinction in several chemotypes, 
those according to the predominance of some 
constituents present in the essential oil. Several 
authors intended to classify the chemotypes, but there 
is no broad consensus about the topic. Matos (2007), 
for instance, classified L. alba in three chemotypes: I, 
II and III. The type I has citral-myrcene 
predominance; type II has citral-limonene 
predominance and type III has carvone-limonene 
predominance. Januzzi et al. (2011) identified five 
essential oil chemotypes of L. alba in the Central-
West region, in the city of Brasilia, and 
these are: limonene-citral, myrcene-citral, myrcene-
neral, citral and linalool. Hennebelle et al. (2008), 
researching the essential oil of L. alba retrieved from 
different regions in France, suggested a classification 
for these oils in seven chemotypes, classifying the 
major components of chemotype I as citral, or 
linalool, or β-caryophyllene; chemotype II as 
tagetenone; the limonene chemotype III followed by 
the various amounts of carvone or monoterpenes 
ketones; the myrcene chemotype IV; the γ-terpinene 
chemotype V; the camphor-1 chemotype VI, cineole-
8 and chemotype VII as estragole. 
Regarding the wide variety of chemotypes 
identified to the L. alba and considering that it is a 
medicinal plant largely employed by the Brazilian 
population and by many other countries around the 
world, this paper proposes a scientific literature 
review to correlate both biological and 
pharmacological properties presented by L. alba 
according to its chemical constitution. 
This systematic review was carried out in 
October 2017 and was performed through PubMed 
Medline, Scopus (Elsevier), Science Direct, SciELO 
and Lilacs via Virtual Health Library (Bireme) using 
several combinations of the following keywords 
Lippia alba and chemotypes. The manuscript 
selection was based on the inclusion criteria: articles 
published in English, Portuguese and Spanish and 
articles with keywords in the title, abstract or full-
text. 127 articles were identified. However, 24 papers 
were indexed in two or more databases and were 
considered only once. Out of this total, 35 articles 
were selected as the others did not meet the inclusion 
criteria. For the selection of the manuscripts, three 
investigators first selected the articles according to 
title, then to abstract and then through an analysis of 
the full-text publication. Any disagreement was 
resolved through a consensus between the 
investigators. The resulting articles were manually 
reviewed with the goal of identifying and excluding 
the studies that did not fit the criteria described 
above. 
 
THE PHARMACOLOGICAL ACTIONS OF 
Lippia alba 
Activities in the Central Nervous System (CNS) 
Experimental studies indicate that the essential oil of 
L. alba with high levels of carvone (around 55%) 
presents anxiolytic properties, supporting previous 
findings reporting the efficacy on repeated treatments 
Louchard et al                                                                                                   Pharmacological effects of different chemotypes of Lippia alba 
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/97 
 
 
with carvone as a powerful depressant in the Central 
Nervous System. This specific study suggests that 
carvone possibly interacts with GABA receptors in 
the brain, inhibits neurons and modulate the behavior 
inhibition (Vale, 1999). There is evidence that 
carvone reaches certain brain areas, such as the 
cerebellar amygdala, the main cerebral area 
responsible for the integration of emotional responses 
and related to the recognition of potentially pleasant 
stimuli to the individual (Hatano et al., 2012). 
The citral-limonene chemotype essential oil, 
when injected intraperitoneally in rats, presented 
anxiolytic, sedative, antipyretic and myorelaxant 
effects in behavioral evaluation tests (Vale, 1999). In 
another study, the evaluation of isolated substances 
as citral, myrcene, and limonene, which are present in 
the essential oil of L. alba, exposed sedative and 
myorelaxant effects, in addition to the pentobarbital 
potentiation on rodents. However, these isolated 
substances do not present anxiolytic actions, 
suggesting that the activity must be a result of non-
major components in the essential oil of the plant 
(Vale et al., 2002). 
Hennebelle et al. (2008) investigated the 
sedative properties of metabolites in the citral 
chemotype essential oil (EO) of L. alba and 
confirmed a weak to moderate action on the 
benzodiazepine receptors. 
The anticonvulsant effects of essential oil in 
three chemotypes of L. alba (citral, myrcene, and 
limonene) were evaluated in a model of 
pentylenetetrazole-induced seizure in mice. The 
results demonstrated the three chemotypes evaluated 
increased the latency of pentylenetetrazole-induced 
seizures. It was also observed a significant increase 
of the anticonvulsant effect in the essential oils 
evaluated with diazepam. The survival rate increased 
from two to three times with essential oil and 
diazepam together in relation to the essential oil in 
the absence of diazepam. It was also demonstrated 
that citral creates an anticonvulsant effect in a smaller 
dose when compared to beta myrcene and limonene. 
Other authors suggest that these constituents present 
pharmacological effects similar to the diazepines 
(Viana et al., 2000). 
 
Mucolytic Action 
Matos (2007), studying the essential oil from L. alba 
in the state of Ceará, observed that the plants with 
high levels of limonene-carvone (chemotype III) 
present mucolytic action. 
 
Analgesic and Anti-inflammatory Activities 
Viana et al. (1998) analyzed the effects of essential 
oils from L. alba citral-limonene and carvone-
limonene chemotypes, in models of a hot plate, acid-
induced abdominal writhing and formalin test in 
mice; carrageenan-induced paw edema and dextran in 
rats. The results revealed that the two chemotypes 
tested caused inhibition to the acetic acid-induced 
writhing and showed significant results in the 
formalin test (inflammatory phase), indicating the 
possible participation of inflammatory mediators in 
the nociceptive effects from the evaluated oils. In the 
hot plate test, the latency for the thermal stimulus 
was increased only with the citral-limonene 
chemotype, this effect is reversed by the opioid 
agonist naloxone, thus suggesting a central analgesic 
action together with the opioid system. The 
carrageenan-induced paw edema or dextran test 
revealed a significant antiedematogenic effect for 
both chemotypes tested (Viana et al., 1998). 
 
Anesthetic action in fish 
Studies of anesthesia induction in fish utilizing the 
Tambaqui species (Colossoma macropomum) proved 
that the citral chemotype essential oil from L. alba, 
whose major components were geranial (25,4%), 
neral (16,6%) and caryophyllene oxide (16%), 
induced fast anesthetic effect (<4 min) in 200 and 
300 mg L-1 doses (Batista et al., 2018). 
 
Activities in Gastrointestinal Tract: Gastroprotective 
activity  
Some studies have proved the gastroprotector action 
of major constituents in the essential oil of L. alba 
species, among them the 1,8 cineole (Santos & Rao, 
2001), citral (Ortiz et al., 2010), limonene (Moraes et 
al., 2009), linalool (Barocelli et al., 2004). 
A study carried with L. alba essential oil 
retrieved in the state of Ceará, myrcene-citral 
chemotype, showed mild antispasmodic property 
related to the citral component (Matos, 2007).  
 
Antispasmodic 
The antispasmodic effect was evaluated in the model 
of ileum and duodenum isolated organs in rats, from 
two L. alba chemotypes (citral and linalool), both 
grown in the region of La Plata, Argentina. The citral 
chemotype is constituted by geranial (19,5%), 
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carvone (16,7%) and neral (11,5%). The linalool 
chemotype presents linalool (64,2%) and 1-8 cineole 
(6%) in its composition. The results illustrate that the 
citral chemotype presented a potential five times 
greater than the linalool chemotype to inhibit 
muscarinic contractile responses. Both chemotypes 
interfered in calcium concentration (Ca2+ -influx), 
presenting an IC50 nearly 28 times higher than 
verapamil concentration. Besides, the citral 
chemotype partially stimulated the production of 
nitric oxide. The authors suggest that this work 
validates the essential oil efficacy based on the two L. 
alba chemotypes (citral and linalool) for the 
treatment of spasmodic visceral diseases, providing 
an alternative to L. alba infusions or its tinctures. 
(Blanco et al., 2013). 
In another study, the chemical composition 
and the pharmacological effects of two chemotypes 
of L. alba essential oil were evaluated: “citral” (COE) 
and “linalool” (LOE), in isolated ileum and 
duodenum of rats. COE had limonene, neral, geranial 
and (-) – carvone as major components, whereas LOE 
presented linalool as its major component. The 
contractile curves of concentration-response (CRC) 
regarding acetylcholine (ACh) and K+ 40 mM 
calcium (Ca2+-CRC) were conducted on isolated 
intestinal portions, in the absence and presence of 
COE or LOE, both in different amounts. The results 
showed that verapamil, COE and LOE induced an 
ACh-CRC non-competitive inhibition, with an IC50 
of 7,0 ± 0,3 mg COE/mL and 37,2 ± 4,2 mg 
LOE/mL. O l-NAME, a NO-synthase blocker, 
increased the IC50’s COE to 26,1 ± 8,7 mg COE/mL. 
In the same way, verapamil, COE and LOE did not 
inhibit competitively Ca2+ -CRC, with a CI50 of 6,3 ± 
1,7 mg COE/mL, 7,0 ± 2,5 mg LOE/mL and 0,24 ± 
0,04 mg verapamil/mL (pIC50: 6,28). In this sense, it 
became clear that COE has five times higher 
potential than LOE to inhibit the muscarinic 
contractile responses. The essential oils from both 
chemotypes interfered in Ca2+ flux, although with the 
IC50 nearly 28 times higher than verapamil. In 
addition, the COE partially stimulated the NO 
production. These results prove the medicinal value 
of both L. alba chemotypes, thus validating its 
traditional usage, pharmacological potency, and 
mechanism of action (Blanco et al., 2013). 
In a work conducted by Carvalho et al. 
(2018), it was evaluated the effect of the L. alba 
essential oil (LaEO) composed by citral 75.92% 
[geraniol (41.81%) and neral (34.11%)], limonene 
(9.85%), carvone (8.92%), gamma-terpinene 
(2.05%), cymene (1.02%) and its major constituents 
citral and limonene, isolated, on the tracheal smooth 
muscle of Wistar rats. The results demonstrated that 
LaEO, citral, and limonene promoted tracheal smooth 
muscle relaxation in the potassium-induced 
contractions (60 mMK), presenting an EC50 of 148 ± 
7 μg/mL for LaEO, 136 ± 7 μg/mL for citral and 581 
± 7 μg/mL for limonene. In the acetylcholine-induced 
contractions (Ach; 10 μM), the CE50 for LaEO and 
citral was, respectively, 731 ± 5 μg/mL and 795 ± 9 
μg/mL. In preincubated preparations with 1000 
µg/mL of LaEO and citral, both agents blocked the 
influx of BaCl2 by VOCCs. These results suggest that 
LaEO and citral have low activity in the muscarinic 
receptors and, thus, promote little or none Ca2+ influx 
through the calcium channels depending on the 
binder (SOCCs and ROCCs), since they require 
secondary signaling messengers (IP3) and 
diacylglycerol (DAG), activated by the active ACh. 
The inhibition of the contractions caused by BaCl2 
suggests an interaction between the LaEO and citral 
with the VOCC receptors, which mediates the Ca2+ 
influx through the channel activation, due to the 
changes on the membrane potential. This study 
demonstrated that the LaEO and its main citral 
component presents antispasmodic effect on the 
tracheal smooth muscle of rats and the limonene has 
less potential than LaEO and citral, and it does not 
act through the cationic Ca2+ influx voltage-operated 
through the channels (Carvalho et al., 2018). 
 
Antimicrobial, antifungal and antiviral activities 
Some recent researches highlight that the essential oil 
of L.alba in its citral chemotype is an alternative to 
synthetic fungicides and it can be used in organic 
agriculture (Glamoclija et al., 2011). Costa et al. 
(2014) confirmed the activity of L. alba EO in its 
linalool chemotype against dermatophyte fungi. 
The antifungal activity in two essential oils of 
L. alba, citral and carvone chemotypes, were 
evaluated against Candida parapsilosis, Candida 
krusei, Aspergillus flavus and Aspergillus fumigatus. 
The results showed that the most active essential oil 
was the citral chemotype, with minimal inhibitory 
concentration (MIC) of 78,7 and 270, 8 ng/mL for, 
respectively, A. fumigatus and C. krusei. The isolated 
citral substance, which is available commercially, 
showed an antifungal activity similar to the essential 
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oil citral chemotype (MIC values being 62,5 ng/mL 
to A.fumigatus and 39,7 μg/mL to C. krusei). The L. 
alba EO citral chemotype antifungal activity 
demonstrated in this study can be explained by a 
large concentration of oxygenated monoterpenes, 
such as neral/geranial (54%) and nerol/geraniol 
(8,9%) (Mesa-Arango, 2009). 
In another study, the essential oil of L. alba – 
citral or neral chemotype – presented strong 
antimicrobial activity against Escherichia coli, 
Bacillus subtilis and Staphylococcus aureus 
(Barbosa, 2003). 
L. alba antiviral activity was evaluated in 
vitro against the Human Herpesvirus-1 (HSV-1) in 
twenty EO samples collected in different regions 
across Colombia. In the collected essential oil 
samples, two chemotypes were identified: citral and 
carvone. The essential oils classified as “citral” 
chemotype (a mixture of neral and geranial isomers) 
present citral content (42–56%), followed by geraniol 
(7-16%) and trans-β-caryophyllene; the oils classified 
as chemotype "carvone" present carvone content (34–
39%), followed by limonene (22–31%) beta-
sesquifelandren (5–13%) and piperitenone (5–6%). 
The results demonstrated that the citral chemotype 
oils, as well as isolated major components, do not 
present activity against herpes simplex virus 1 in the 
tested amounts, which included cytotoxic and non-
cytotoxic concentrations. However, the carvone 
chemotype showed moderate antiherpetic activity in 
vitro, in monolayers of infected HeLa cells, with 
values of Rf as 1x101, 5 in concentrations from 125 
μg/mL to 250 μg/mL. The positive controls, heparin 
sulfate, and acyclovir reduced the virus titer with Rf 
values to the order of 1x10² and 1x104. None of the 
isolated monoterpenes showed activity against the 
HSV-1 (Agudelo-Gomez et al., 2010). 
 
Leishmanicidal action 
Regarding the antileishmanial activity, the citral 
chemotype essential oil of L. alba was active against 
the extracellular forms of Leishmania Viannia 
braziliensis, in addition to the activity against the 
intracellular parasite form, being 2,8 times more 
selective to the parasite than the cells. The 
amphotericin B showed higher antiparasitic activity 
against the intracellular amastigotes of Leishmania 
Viannia braziliensis than against Leishmania Viannia 
panamensis, with an IS of 196 and 32, respectively. 
The essential oil displayed additional toxic effects in 
THP-1 cells (Neira et al., 2018). 
 
Repellent and toxic activity for insects 
The acaricide activity of L. alba essential oil, citral 
chemotype (44-46% geranial, 31-33% neral) and 
carvone chemotype (35-63% carvone and 25-27% 
limonene) were evaluated against the Rhipicephalus 
microplus tick. The acaricide efficacy was evaluated 
by the larval and immersion test in engorged females. 
The citral chemotype presented a higher larvicidal 
activity than the carvone chemotype, corroborating 
with the results obtained to the isolated citral, which 
presented larvicidal and adulticide activity with CL50 
values of 7,0 and 29,8 mg/mL, respectively. The 
isolated carvone showed a higher larvicidal activity 
than limonene, with R - (+) displaying a significant 
higher efficacy (CL50 values of 31,2 mg/mL) than S - 
(-) (CL50 values of 54,5 mg / mL). For the test with 
engorged female adults, both the essential oils and 
their isolated major components were less toxic, with 
the exception of citral, and this may be due to the 
limited cuticular penetration. Therefore, in this study, 
the essential oil citral chemotype presented a higher 
larvicidal efficacy than the carvone chemotype. The 
authors suggest that these results represent a green 
alternative to the tick control in bovines (Peixoto et 
al., 2015a). 
The repellant and toxic activity were 
evaluated against Sitophilus zeamais and Tribolium 
castaneum, which are insects that cause the loss of 
stored grains and considered as a widely distributed 
pest and global significance. Essential oils from 
different chemotypes of L. alba (carvone chemotypes 
LA-13 and LA-57 and citral chemotypes LA-10 and 
LA-44) and their main monoterpenes, carvone and 
citral, were evaluated. The bioassays of toxicity 
exposure of insects in treated filter paper were 
performed to determine the concentration and the 
lethal time. Repellency tests were conducted utilizing 
the most toxic compounds according to the toxicity 
bioassays. The carvone chemotypes were more toxic 
than the citral chemotype for two species: for the S. 
zeamais species, the CL50 values were 15,2 μL/mL 
(LA-13) and 16,7 μL/mL (LA-57) and for the T. 
castaneum species, the LC50 values were 28,7 μL/mL 
(LA-13) and 19,7 μL/mL (LA-57). The isolated 
carvone (CL50 = 8,8 μL/mL) was more toxic than the 
citral. For the S. zeamais, the citral monoterpene 
presented the shortest lethal time (LT50 = 6 h), 
whereas, for the T. castaneum, the carvone and citral 
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monoterpenes presented faster toxicity (LT50 = 7,3 h). 
The tested compounds were highly repellant to the T. 
castaneum; however, no repellant effect was 
observed against the S. zeamais, except for the LA-13 
chemotype. The authors suggest that the L. alba 
carvone chemotype oils, in addition to the 
monoterpene carvone isolated components, have the 
potential for the development of natural insecticides 
against the S. zeamais and T. castaneum insects 
(Peixoto et al., 2015b). 
 
Cytotoxic and mutagenic activities 
Two essential oils of L. alba, citral, and carvone 
chemotypes, were evaluated for their toxicity in Vero 
and HeLa cells culture. The essential oil of citral 
chemotype, containing 23,6% of neral and 30,5% of 
geraniol, demonstrated higher cytotoxic activity in 
the tumoral line HeLa and the lower activity in the 
cellular line Vero. The carvone chemotype essential 
oil did not demonstrate a cytotoxic effect. The 
absence of cytotoxicity in the carvone chemotype can 
be explained by the low content of citral oxygenated 
monoterpene (20,8%) compared to the citral 
chemotype (54,1%) or by the fact the major 
compounds (limonene and carvone) in the carvone 
chemotype essential oil are antagonists to the citral 
oxygenated monoterpene. The citral chemotype was 




The essential oil genotoxic properties of two 
chemotypes of L. alba collected in Bucaramanga 
(Colombia) were evaluated. The citral chemotype 
(geranial 33.1%, neral 25,4%, trans beta 
caryophyllene 6,6%) and the carvone-limonene 
chemotype (carvone 38,1%, limonene 33,2%, beta- 
sesquiphellandrene 6%) did not present genotoxicity, 
although one of the isolated components – limonene 
– presented genotoxicity in doses between 97 and 
1549 mM. Both chemotypes protected bacterial cells 
against the bleomycin-induced genotoxicity. 
Antigenotoxicity in two chemotypes of L. alba seems 
to be linked to citral and carvone compounds 
respectively. (López et al., 2011).  
On the other hand, the citral chemotype 
essential oil of L. alba collected in Colombia, being 
used as a treatment of 100 mg/kg for 14 days (orally) 
did not induce physical changes such as 
weight loss or pain signal increase in the treated 
animals. However, this treatment induced a slight 
damage to the DNA, with damage values around 
23%. The induced damage by the cyclophosphamide 
positive control (CPA) was three times higher (74,9 ± 
3,2%) with significant differences (p<0,001) between 
them. The essential oil did not display the formation 
of micronuclei in erythrocytes of polychromatic bone 
marrow. By contrast, the genotoxicity positive 
control CPA showed the frequency of 175 ± 18,8 MN 
in 1000 polychromatic erythrocytes (Neira et al., 
2018). 
 
Antioxidant and adaptogenic activity 
The effects of the addition of essential oil of L. alba 
of linalool chemotype in the diet of silver catfish 
were evaluated. These effects were evaluated 
following blood, metabolic, growth and oxidative 
stress biomarkers parameters. The essential oil 
evaluated in this study presented, as major 
compounds, linalool (55.26%), 1,8-cineole (7.85%), 
and γ-muurolene (4.63%). The results demonstrated 
the diet containing essential oil of L. alba did not 
influence in the blood and growth and blood 
parameters of these animals. However, the diet 
decreased the glucose levels and increased liver 
glycogen stores. The amount of essential oil, in the 
ratio of 1,0 ml per kilogram of feed, increased the 
lactate levels in the liver; 0,5 mL/kg increased the 
glycogen levels in the muscle; the antioxidant 
response of tissues was also increased by the 
essential oil diet. The authors suggest the essential oil 
of L. alba may have caused the sedation and 
decreased metabolism, thus increasing both liver and 
muscle glycogen stores and the antioxidant responses 
in different tissues as well, a mechanism 
demonstrating the theory of adaptation (Saccol et al., 
2013). 
Puerta-Meija et al., (2002) demonstrated low 
antioxidant activity in the essential oil from 
Colombia, having carvone (61%) as the major 
compound (Puertas‐ Mejía et al., 2002). Another 
study performed by Stashenko et al. (2003) 
highlighted visible antioxidant activity, comparable 
to vitamin E. The major compounds from this study 
were carvone and limonene, suggesting that the 
antioxidant action could be attributed to the presence 
of limonene (Stashenko et al., 2003). 
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Activities in the Cardiovascular System 
Maynard et al. (2011) investigated the essential oil of 
L. alba effect containing, as major constituents, 
geranial (48,58%) and neral (35,42%) on the 
mesenteric artery of rats. The results demonstrated an 
endothelium-independent vasorelaxation, which is 
caused, seemingly and partially, by the calcium 
influx blockage, mediated by the voltage-operated 
calcium channels. 
 
Clinical Trial for patients with headaches 
(migraines) 
It was realized a phase II cohort, non-controlled and 
prospective clinical trial to evaluate the therapeutic 
effects of L. alba on patients with migraines. The 
patients received hydroalcoholic extracts from leaves. 
The intensity and frequency of the symptoms were 
monitored before and after 30-60 days of treatment. 
The study demonstrated that the chemotype 
containing carvone and geraniol as its major 
compounds was able to significantly reduce the 
frequency and intensity in the pain episodes. Over 
80% of the volunteers experienced a minimal 
reduction of 50% in pain frequency and intensity, 
with no observed side effects (Conde et al., 2011). 
 
Non-clinical toxicity evaluation: Dermal toxicity  
The citral chemotype EO of L. alba, when submitted 
to dermal toxicity evaluation assay (OECD method, 
2015) did not present toxicity to 10, 50 and 100% 
concentrations, being considered as non-irritating 
(Neira et al., 2018). 
 
Acute oral toxicity 
The evaluation for citral chemotype EO of L. alba 
acute oral toxicity was conducted utilizing the 
maximum oral dose of 2000 mg/kg. The results 
demonstrated the animals treated with citral 
chemotype EO of L. alba did not show clinical signs 
of systemic toxicity, with a survival rate of 100%. 
Major statistic differences in the weight of the 
animals before and after the treatment (weight of 
22,47 ± 0,9 g versus 22,74 ± 1,0g) were not observed, 
as well as pain signs or behavior change during the 
days of treatment. The weight and daily consumption 
of food happened as expected, exhibiting well-being. 
The macroscopic analysis of the organs did not show 
any changes, thus presenting a normal aspect. (Neira 
et al., 2018). 
In another study, mice treated orally with a 
single dose (1500 mg/kg) of citral chemotype 
essential oil of L. alba (geranial 45,3%, neral 30,23% 
and beta-farnesene 7,78%) presented a survival rate 
around 60%. Lowering the dose (300 and 900 mg / 
kg) there was a 100% survival rate, with slight signs 
of ataxia, lethargy, salivation and transitory seizures. 
The effect produced by this chemotype, according to 
the authors, is related to the action that citral has on 
the central nervous system, due to the inhibitory 
activity of citral on the synthesis of retinoic acid, an 
essential metabolite for the neuronal differentiation 
and development (Zhang et al., 2009; Aular et al., 
2016). 
The Table N° 1 shows ten chemotypes 
quoted in the publications and their different 
biological activities. Table N° 2 presents the 
pharmacological actions with its respective isolated 
substances from the essential oils of L. alba.  
 
CONCLUSION 
The studies indicate the carvone, citral-limonene, and 
citral chemotypes present pharmacological 
depressant activity in the central nervous system, 
acting on anxiety control. These studies corroborate 
with the traditional usage of Lippia alba, which is 
designated as tranquilizer, sedative, anxiolytic.  
The broad array of pharmacological activities 
presented by the several chemotypes in the essential 
oil of L. alba demonstrate the importance of the 
chemical monitoring of the species for the definition 
of the clinical application of essential oil. In this 
sense, defining the chemotype and monitoring the 
content of its constituents is paramount for the 
development of drugs from this species. 
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Table N° 1 
Pharmacological effects of different chemotypes of Lippia alba 
Essential oil Chemotype Pharmacological Activity Reference 
 
            Carvone 
Anxiolytic Vale, 1999 
Anti-herpetic Agudelo-Gomez et al., 
2010 
Antigenotoxic Lopez et al., 2011 
Repellant and Toxic against 
Sitophilus zeamais and 
Tribolium castaneum 














Moderate action on the 
benzodiazepine receptors 
Hennebelle et al., 2008 
Cytotoxic in the tumoral line Mesa-Arango, 2009 
Anticonvulsant Viana et al., 2000 
Antispasmodic Blanco et al., 2013, 
Carvalho et al., 2018 
Antifungal Glamočlija et al., 2011, 
Mesa-Arango, 2009 
Antimicrobial Barbosa, 2003 
Acaricide Peixoto et al., 2015a 
Leishmanicidal Neira et al., 2018 
Antigenotoxic Lopez et al., 2011 
Vasorelaxant Maynard et al., 2011 
Anesthetic Batista et al., 2018 
Myrcene Anticonvulsant Viana et al., 2000 
Limonene Anticonvulsant Viana et al, 2000 
Antispasmodic Carvalho et al, 2018 
Limonene-carvone Mucolytic Matos, 2007 
Carvone-limonene Anti-inflammatory, 
antiedematogenic 
Viana et al., 1998 
Antioxidant Stashenko et al., 2003 
Myrcene-citral Antispasmodic Matos, 2007 
Linanool  Antifungal Costa et al., 2014 
Antispasmodic Blanco et al., 2003 
Antioxidant Saccol et al., 2013 
Adaptogenic Saccol et al., 2013 
Carvone-citral                    
(geraniol) 
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Table N° 2 
Pharmacological effects of major constituents in the essential oil of L. alba species 





Sedative and myorelaxant, in 
addition to the pentobarbital 
potentiation on rodents 
Vale et al., 2009 
Anticonvulsant Barbosa, 2003 




Sedative and myorelaxant, in 
addition to the pentobarbital 
potentiation on rodents 
Vale et al., 2009 




Sedative and myorelaxant, in 
addition to the pentobarbital 
potentiation on rodents 
Vale et al., 2009 
Anticonvulsant Barbosa, 2003 
Gastroprotective Moraes, et al., 2009 
1,8 cineol Gastroprotective Santos & Rao, 2001 
Linalool Gastroprotective Barocelli et al., 2004 
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